Role of interventional therapy in patients with coronary heart disease and life-threatening ventricular tachyarrhythmias.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 8223748.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study includes 357 patients with coronary heart disease and life-threatening ventricular tachyarrhythmias. Thirty-three patients (10%) underwent direct current (DC) catheter ablation (group 1), 121 (34%) mapping-guided surgery (group 2) and 203 (56%) received an implantable cardioverter defibrillator (ICD) (group 3). The mean follow-up was 35 +/- 25 months in group 1, 41 +/- 37 months in group 2 and 22 +/- 22 months in group 3. During follow-up, 6 patients (18%) died in group 1, 45 (37%) in group 2 and 46 (23%) in group 3. Sudden death occurred in two patients (6%) in group 1, 10 patients (8%) in group 2 and eight patients (4%) in group 3. Non-fatal recurrences group were observed in 19 patients (57%) in group 1 and in 16 patients (14%) in group 2. ICD discharges occurred in 175/203 patients (86%) in group 3 with a mean number of 18 +/- 28 ICD shocks per patient. Our data show that catheter ablation has a low incidence of sudden death but a high incidence of non-fatal recurrences. Mapping-guided surgery yields low rates of sudden death or recurrence. Patients with an ICD have a low sudden death rate. A treatment algorithm is necessary to evaluate patients at high risk for sudden death and to choose the right patient for the right treatment.
Medical subject headings
- Catheter Ablation
- Coronary Disease
- Defibrillators, Implantable
- Tachycardia, Ventricular